GLENMARK options
Glenmark Pharma option chain and implied move
| Metric | Value | Read |
|---|---|---|
| Market-implied move | ±₹41.20 | ±1.90% to the Tuesday, 27 October 2026 expiry, from the at-the-money straddle |
| Implied range | ₹2,125.40 – ₹2,207.80 | What option prices imply, not a forecast of where the stock will trade |
| Max pain | ₹2,220 | The strike at which the largest value of written options would expire worthless |
| Heaviest put strike | ₹2,100 | 97,500 contracts — the largest put position on the chain |
| Heaviest call strike | ₹2,300 | 3,13,875 contracts — the largest call position on the chain |
| Put-call ratio | 0.51 | Total put open interest divided by total call open interest across the chain |
| Implied volatility (ATM) | 20.02% | At-the-money implied volatility for the front expiry |
- Market-implied move
- ±₹41.20
- Implied range
- ₹2,125 – ₹2,208
- Max pain
- ₹2,220
- Implied volatility
- 20.02%
±1.90% over 4 days, from the ₹2,160 straddle
What option prices imply, not a forecast of where the stock will trade
₹53 above the close
At the money, for the front expiry
Implied rangeMax painLast close
Heaviest put ₹2,100Heaviest call ₹2,300ATM ₹2,160 · PCR 0.51
At the close on Friday, 23 October 2026, Glenmark Pharma options were pricing a move of ±₹41.20 by the Tuesday, 27 October 2026 expiry — a range of ₹2,125.40 to ₹2,207.80 against a closing price of ₹2,166.60. The figure is the at-the-money straddle at the ₹2,160 strike, which is what the options market itself is charging for the move to expiry. It describes the price of that expectation, not a forecast MarketCue makes.
Max pain sits at ₹2,220, ₹53.40 above the closing price — the strike at which the largest value of written options would expire worthless. The heaviest put position on the chain is at ₹2,100 with 97,500 contracts, and the heaviest call position at ₹2,300 with 3,13,875 contracts. Open interest describes where positions have been built; it is not a commitment by anyone to defend a price.
At-the-money implied volatility was 20.02% for the Tuesday, 27 October 2026 expiry. Realised volatility for Glenmark Pharma is not yet available for comparison.
This page is a record of where Glenmark Pharma's chain finished on Friday, 23 October 2026, not a live feed — the next reading follows tomorrow's close. Figures are derived from the NSE option chain via Upstox; max pain, the implied move, put-call ratio and the volatility comparison are MarketCue's own calculations from that data. MarketCue is not a registered investment adviser, research analyst or broker under SEBI regulations, and nothing here is a recommendation to buy or sell any security.
Read the full MarketCue scoring methodology
Source: NSE option chain via Upstox. .
Frequently asked questions
- What move are Glenmark Pharma options pricing this expiry?
- ±₹41.20, or 1.90%, giving a range of ₹2,125.40 to ₹2,207.80 by Tuesday, 27 October 2026. The figure is derived from the at-the-money straddle at the ₹2,160 strike.
- What is Glenmark Pharma's max pain?
- ₹2,220 at the last close, against a closing price of ₹2,166.60. Max pain is the strike at which the largest value of written options would expire worthless.
- Where is support and resistance in the Glenmark Pharma option chain?
- The largest put position sits at ₹2,100 with 97,500 contracts, and the largest call position at ₹2,300 with 3,13,875 contracts. Traders commonly read heavy open interest at a strike as a level, though open interest describes positioning rather than any commitment to defend a price.
- What is the lot size for Glenmark Pharma options?
- 375 shares per lot, with strikes in steps of ₹20. At the implied move of ±₹41.20, one lot corresponds to ±₹15,450 of notional movement.